dilluns, 17 de novembre del 2014

Histogenics sets range for $60m IPO




Histogenics sets the per-share price range for its upcoming initial public offering, setting the midpoint at $60 million.






Histogenics set the per-share price range on its forthcoming initial public offering at $13 to $15 per share.


That puts the mid-point for the nearly 4.3 million-share offering at just under $60 million.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uFp9A9

Cap comentari:

Publica un comentari a l'entrada